The global clinical trial packaging market was valued at $2,582.5 million in 2021, and is projected to reach $6,213.7 million by 2031, registering a CAGR of 9.1% from 2022 to 2031. Packaging of clinical trial equipment are the packing solutions integrated at the primary level, secondary level, and transportation level of packaging. Packaging plays a very crucial role, especially in case of medical devices. Moreover, it provides a protective layer and further offers convenient handling options. Third level packaging or transportation level packaging prevents any kind of goods in transit. Along with the protective layer, packaging keeps medical devices sterile and free from any kind of contamination. With the introduction of smart packing solutions, the packing industry has completely developed, which further propels the market growth.
Factors such as technological developments in the medical device industry, introduction of several advanced medical devices that require specialized packaging, and increased demand for innovative packaging solutions, owing to increase in production and supply of medical devices, medicines and drugs across the globe, which further drives the market growth. In addition, increase in spending on healthcare services, owing to rising health awareness also boosts the clinical trial packaging market growth.
However, strict rules & regulations imposed by governments across the globe hamper the global clinical trial packaging market. In addition, rise in need for sterile packaged, tamper-proof, and nonreactive products with great performance and reducing total cost of ownership boosts technological advancements in the global clinical trial packaging market, thereby creating huge opportunities for growth of the market during the forecast period.
The global clinical trial packaging market segmented on the basis of packaging type, material, end user, and region. On the basis of packaging type, it is classified into syringes, vials & ampoules, bottles, bags & pouches and others. By material, it is divided into plastic, glass, metal, paper, and corrugated fiber. By enduser, it is categorized into research laboratories, clinical research organizations, and drug manufacturing facilities. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major players profiled in the global clinical trial packaging market include, Almac Group Limited, 3M Company, Bilcare Limited, Corden Pharma International, Thermo Fisher Scientific Inc., Mawdsley-Brooks & Co. Ltd., Parexel International Corporation, Piramal Enterprises Ltd., Sharp Services, LLC, Caligor Coghlan, Next Pharma Technologies Holding Limited, PCI Pharma Services, Sentry BioPharma Services, Westrock Company, Körber Medipak Systems AG, WuXi AppTec, and Xerimis Inc.
Factors such as technological developments in the medical device industry, introduction of several advanced medical devices that require specialized packaging, and increased demand for innovative packaging solutions, owing to increase in production and supply of medical devices, medicines and drugs across the globe, which further drives the market growth. In addition, increase in spending on healthcare services, owing to rising health awareness also boosts the clinical trial packaging market growth.
However, strict rules & regulations imposed by governments across the globe hamper the global clinical trial packaging market. In addition, rise in need for sterile packaged, tamper-proof, and nonreactive products with great performance and reducing total cost of ownership boosts technological advancements in the global clinical trial packaging market, thereby creating huge opportunities for growth of the market during the forecast period.
The global clinical trial packaging market segmented on the basis of packaging type, material, end user, and region. On the basis of packaging type, it is classified into syringes, vials & ampoules, bottles, bags & pouches and others. By material, it is divided into plastic, glass, metal, paper, and corrugated fiber. By enduser, it is categorized into research laboratories, clinical research organizations, and drug manufacturing facilities. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major players profiled in the global clinical trial packaging market include, Almac Group Limited, 3M Company, Bilcare Limited, Corden Pharma International, Thermo Fisher Scientific Inc., Mawdsley-Brooks & Co. Ltd., Parexel International Corporation, Piramal Enterprises Ltd., Sharp Services, LLC, Caligor Coghlan, Next Pharma Technologies Holding Limited, PCI Pharma Services, Sentry BioPharma Services, Westrock Company, Körber Medipak Systems AG, WuXi AppTec, and Xerimis Inc.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the clinical trial packaging market analysis from 2021 to 2031 to identify the prevailing clinical trial packaging market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the clinical trial packaging market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global clinical trial packaging market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Packaging Type
- Syringes
- Vials Ampoules
- Bottles
- Bags Pouches
- Others
By Material
- Plastic
- Glass
- Metal
- Paper
- Corrugated Fiber
By End-user
- Research Laboratories
- Clinical Research Organizations
- Drug Manufacturing Facilities
By Region
- North America
- Mexico
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
Key Market Players
- 3M
- PAREXEL International Corporation
- Fisher Clinical Services, Inc.
- The Coghlan Group, Inc.
- Mawdsley-Brooks & Co. Ltd
- Piramal Enterprises Ltd
- Sharp
- Corden Pharma GmbH
- Bilcare Limited
- Westrock Company
- Sentry BioPharma Services
- PCI Pharma Services
- NextPharma Technologies Holding Limited
- Körber Medipak Systems AG
- WuXi AppTec
- Almac Group Limited
- Xerimis Inc
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE
CHAPTER 5: CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL
CHAPTER 6: CLINICAL TRIAL PACKAGING MARKET, BY END-USER
CHAPTER 7: CLINICAL TRIAL PACKAGING MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, titled, “Clinical Trial Packaging Market," the clinical trial packaging market size was valued at $2.58 billion in 2021, and is estimated to reach $6.21 billion by 2031, growing at a CAGR of 9.1% from 2022 to 2031. Clinical trial packaging is an important factor to place devices in the market safe and secured during the shelf life. Packaging performs protection and communication with the environment, humans, and vice versa. For a medical device, protection is necessary by maintaining package integrity, usually, proper packaging is required for medical equipment to avoid, physical damage, biological contamination, and other external disturbance. In addition, other motive is the proper identification of the device by means of labeling.Rapid advancements in the technology involved in medical equipment, coupled with introduction of new and innovation devices require specialized and smart packing solutions, which also drives the market growth. Moreover, increase in number of patients with acute and chronic ailments have a direct and positive impact on the demand for clinical trial packaging, rise in environmental concerns, coupled with increased expenditure on healthcare infrastructure has led to production and innovation of eco-friendly packing solutions. However, strict rules & regulations imposed by the government across the world may hamper the global clinical trial packaging market growth. Conversely, increase in need for sterile packaged, tamper-proof, and nonreactive products with great performance & reducing total cost of ownership are few factors that create lucrative opportunities for the clinical trial packaging industry in the future.
The global clinical trial packaging market segmented on the basis of packaging type, material, end user, and region. On the basis of packaging type, it is further classified into syringes, vials & ampoules, bottles, bags & pouches and others. By material, it is divided into plastic, glass, metal, paper, and corrugated fiber. By end user, it is categorized into research laboratories, clinical research organizations, and drug manufacturing facilities. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major players profiled in the global clinical trial packaging market analysis include, Almac Group Limited, 3M Company, Bilcare Limited, Corden Pharma International, Thermo Fisher Scientific Inc., Mawdsley-Brooks & Co. Ltd., Parexel International Corporation, Piramal Enterprises Ltd., Sharp Services, LLC, Caligor Coghlan, Next Pharma Technologies Holding Limited, PCI Pharma Services, Sentry BioPharma Services, Westrock Company, Körber Medipak Systems AG, WuXi AppTec, and Xerimis Inc.end userend user. Major companies in the market have adopted product launch, partnership, business expansion and acquisition as their key developmental strategies to offer better products and services to customers and boost the clinical trial packaging market share.
Key Findings of the Study
- The report provides an extensive analysis of the current and emerging global clinical trial packaging market trends and dynamics.
- Depending on packaging type, the bags & pouches segment was the largest revenue generator in 2021.
- By material, the plastic segment generated the highest revenue in 2021.
- Based on end user, the research laboratories segment dominated the market in 2021.
- Region wise, North America is anticipated to dominate the global clinical trial packaging market throughout the study period.
- The report provides an extensive analysis of the global clinical trial packaging market opportunities of the market.
- The global clinical trial packaging market forecast analysis from 2022 to 2031 is included in the report.
Companies Mentioned
- 3M
- Parexel International Corporation
- Fisher Clinical Services, Inc.
- The Coghlan Group, Inc.
- Mawdsley-Brooks & Co. Ltd
- Piramal Enterprises Ltd
- Sharp
- Corden Pharma GmbH
- Bilcare Limited
- Westrock Company
- Sentry Biopharma Services
- Pci Pharma Services
- Nextpharma Technologies Holding Limited
- Körber Medipak Systems AG
- Wuxi Apptec
- Almac Group Limited
- Xerimis Inc
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 240 |
| Published | July 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 2582.5 million |
| Forecasted Market Value ( USD | $ 6213.7 million |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
